Octagon Capital Advisors’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $5.86M | Buy |
|
|||||
|
2022
Q4 | $7.2M | Sell |
|
|||||
|
2022
Q3 | $6.2M | Buy |
|
|||||
|
2022
Q2 | $4.67M | Hold |
|
|||||
|
2022
Q1 | $5.94M | Sell |
|
|||||
|
2021
Q4 | $10.6M | Hold |
|
|||||
|
2021
Q3 | $11M | Hold |
|
|||||
|
2021
Q2 | $11M | Hold |
|
|||||
|
2021
Q1 | $9.74M | Buy |
|
|||||
|
2020
Q4 | $11M | Buy |
|